drugset / Trial / NCT07335055
A Study for HSK47388 in Participants With Ulcerative Colitis
Phase 2
Recruiting
150 enrolled
Haisco Pharmaceutical Group Co., Ltd.
Haisco-USA Pharmaceuticals, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .
Timeline
- Start
- 2026-02-03
- Primary completion
- 2027-10-15
- Completion
- 2029-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK47388 | Unknown | — | Oral |